External validation of the United Kingdom-primary biliary cholangitis risk scores of patients with primary biliary cholangitis treated with ursodeoxycholic acid.

Cheung, Angela C; Gulamhusein, Aliya F; Juran, Brian D; Schlicht, Erik M; McCauley, Bryan M; de Andrade, Mariza; Atkinson, Elizabeth J; Lazaridis, Konstantinos N

Cheung, Angela C; Gulamhusein, Aliya F; Juran, Brian D; Schlicht, Erik M; McCauley, Bryan M; de Andrade, Mariza; Atkinson, Elizabeth J; Lazaridis, Konstantinos N.

Afiliación

Cheung AC; Division of Gastroenterology and Hepatology Mayo Clinic Rochester MN.
Gulamhusein AF; Division of Gastroenterology, Toronto Center for Liver Disease University Health Network Toronto ONT Canada.
Juran BD; Division of Gastroenterology and Hepatology Mayo Clinic Rochester MN.
Schlicht EM; Division of Gastroenterology and Hepatology Mayo Clinic Rochester MN.
McCauley BM; Department of Health Sciences Research Mayo Clinic Rochester MN.
de Andrade M; Department of Health Sciences Research Mayo Clinic Rochester MN.
Atkinson EJ; Department of Health Sciences Research Mayo Clinic Rochester MN.
Lazaridis KN; Division of Gastroenterology and Hepatology Mayo Clinic Rochester MN.

Hepatol Commun ; 2(6): 676-682, 2018 Jun.

Article en En | MEDLINE | ID: mdl-29881819

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hepatol Commun Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google